The US Food and Drug Administration (FDA) has debuted new draft guidance that aims to streamline and expedite the biosimilar development process. The regulatory framework has been designed to reduce ...

February 13, 2026) - VRC Medical Services, a women-owned specialty pharmaceutical distribution company supporting clinical research, announced the launch of a dedicated comparator support program ...

The global biosimilar contract manufacturing market size was valued at USD 9.22 billion in 2025 and is predicted to hit ...

Alvotech, a biotech firm focused on biosimilar medicine development, announced the acquisition of Xbrane Biopharma’s R&D operations and a biosimilar candidate named XB003, aimed at extending its ...

Vascular Endothelial Growth Factor Inhibitor market grows 4.0% CAGR as biosimilars and personalized medicine expand ...

(Reuters) -India's Biocon expects a 50% drop in costs for developing complex biosimilars as the United States has proposed to ease clinical testing for the drugs that make up more than 60% of its ...

A drug selected for the latest round of Medicare drug price negotiations stands to get dropped because a lower-cost ...

The European Medicines Agency (EMA) reports on progress to create a smoother, less wasteful biosimilar development process; and the World Health Organization (WHO) revises its biosimilar development ...

Policymakers must turn attention to comparative efficacy data and animal testing requirement waiver, easing enforcement of clinical trial regulation, and integrating AI into clinical trials ...

DUBLIN--(BUSINESS WIRE)--The "Charting the Global Biosimilar pipeline" report has been added to ResearchAndMarkets.com's offering. There are multiple biosimilars in development for a range of therapy ...